ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 123 filers reported holding ANI PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.64 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,659,577 | +788.5% | 28,584 | +723.7% | 0.01% | +1100.0% |
| Q2 2023 | $186,790 | -32.2% | 3,470 | -50.0% | 0.00% | -50.0% |
| Q1 2023 | $275,458 | -2.0% | 6,935 | -20.8% | 0.00% | 0.0% |
| Q3 2022 | $281,000 | -76.4% | 8,751 | -66.2% | 0.00% | -81.8% |
| Q4 2021 | $1,192,000 | +195.0% | 25,869 | +107.0% | 0.01% | +57.1% |
| Q2 2020 | $404,000 | +7.4% | 12,499 | +104.7% | 0.01% | 0.0% |
| Q4 2019 | $376,000 | -34.0% | 6,105 | -22.0% | 0.01% | -36.4% |
| Q3 2019 | $570,000 | +62.4% | 7,824 | +0.2% | 0.01% | -35.3% |
| Q4 2018 | $351,000 | -66.6% | 7,805 | -56.7% | 0.02% | -72.1% |
| Q1 2018 | $1,050,000 | +390.7% | 18,027 | +280.0% | 0.06% | +369.2% |
| Q4 2015 | $214,000 | -79.8% | 4,744 | -72.3% | 0.01% | -75.0% |
| Q2 2015 | $1,061,000 | +415.0% | 17,100 | +368.4% | 0.05% | +372.7% |
| Q4 2014 | $206,000 | – | 3,651 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
| Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
| Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
| Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
| 1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
| THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
| Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
| Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |